BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28723694)

  • 1. Exosomes: A Cancer Theranostics Road Map.
    Panagiotara A; Markou A; Lianidou ES; Patrinos GP; Katsila T
    Public Health Genomics; 2017; 20(2):116-125. PubMed ID: 28723694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidic Exosome Analysis toward Liquid Biopsy for Cancer.
    He M; Zeng Y
    J Lab Autom; 2016 Aug; 21(4):599-608. PubMed ID: 27215792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancements in microfluidic technologies for isolation and early detection of circulating cancer-related biomarkers.
    Rana A; Zhang Y; Esfandiari L
    Analyst; 2018 Jun; 143(13):2971-2991. PubMed ID: 29790491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review: Microfluidics technologies for blood-based cancer liquid biopsies.
    Sun Y; Haglund TA; Rogers AJ; Ghanim AF; Sethu P
    Anal Chim Acta; 2018 Jul; 1012():10-29. PubMed ID: 29475470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfluidic-Based Exosome Analysis for Liquid Biopsy.
    Lin B; Lei Y; Wang J; Zhu L; Wu Y; Zhang H; Wu L; Zhang P; Yang C
    Small Methods; 2021 Mar; 5(3):e2001131. PubMed ID: 34927834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of circulating biomarkers in liquid biopsy diagnostics.
    Yeo JC; Lim CT
    Biotechniques; 2018 Oct; 65(4):187-189. PubMed ID: 30284936
    [No Abstract]   [Full Text] [Related]  

  • 7. A "Clue" to Improving Liquid Biopsies for Cancer: Microfluidic Multiparametric Exosome Analysis.
    Zhang W; Pham TH; Wang DH
    Clin Chem; 2021 Jan; 67(2):335-337. PubMed ID: 33207364
    [No Abstract]   [Full Text] [Related]  

  • 8. Microfluidic systems for cancer diagnostics.
    Garcia-Cordero JL; Maerkl SJ
    Curr Opin Biotechnol; 2020 Oct; 65():37-44. PubMed ID: 31891869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Exosomes to Circulating Tumor Cells: Using Microfluidics to Detect High Predictive Cancer Biomarkers.
    Abreu CM; Caballero D; Kundu SC; Reis RL
    Adv Exp Med Biol; 2022; 1379():369-387. PubMed ID: 35761000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation of distinct exosome subpopulations: isolation and characterization approaches and their associated challenges.
    Singh K; Nalabotala R; Koo KM; Bose S; Nayak R; Shiddiky MJA
    Analyst; 2021 Jun; 146(12):3731-3749. PubMed ID: 33988193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Liquid Biopsy Using Integrated Microfluidic Exosome Analysis Platforms.
    Li G; Tang W; Yang F
    Biotechnol J; 2020 May; 15(5):e1900225. PubMed ID: 32032977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes for Non-Invasive Cancer Monitoring.
    Kalishwaralal K; Kwon WY; Park KS
    Biotechnol J; 2019 Jan; 14(1):e1800430. PubMed ID: 30358137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in integrated microfluidics for liquid biopsies and future directions.
    Zhuang J; Xia L; Zou Z; Yin J; Lin N; Mu Y
    Biosens Bioelectron; 2022 Dec; 217():114715. PubMed ID: 36174359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrically driven microfluidic platforms for exosome manipulation and characterization.
    Diaz-Armas GG; Cervantes-Gonzalez AP; Martinez-Duarte R; Perez-Gonzalez VH
    Electrophoresis; 2022 Jan; 43(1-2):327-339. PubMed ID: 34717000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic-nanowaxberry-based microfluidic ExoSIC for affinity and continuous separation of circulating exosomes towards cancer diagnosis.
    Ding L; Liu X; Zhang Z; Liu LE; He S; Wu Y; Effah CY; Yang R; Zhang A; Chen W; Yarmamat M; Qu L; Yang X; Wu Y
    Lab Chip; 2023 Mar; 23(6):1694-1702. PubMed ID: 36789765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome Theranostics: Biology and Translational Medicine.
    He C; Zheng S; Luo Y; Wang B
    Theranostics; 2018; 8(1):237-255. PubMed ID: 29290805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in Microfluidics-Based Exosome Separation and Detection Technologies for Diagnostic Applications.
    Lin S; Yu Z; Chen D; Wang Z; Miao J; Li Q; Zhang D; Song J; Cui D
    Small; 2020 Mar; 16(9):e1903916. PubMed ID: 31663295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes in cancer theranostic: Diamonds in the rough.
    Cordonnier M; Chanteloup G; Isambert N; Seigneuric R; Fumoleau P; Garrido C; Gobbo J
    Cell Adh Migr; 2017 Mar; 11(2):151-163. PubMed ID: 28166442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome separation using microfluidic systems: size-based, immunoaffinity-based and dynamic methodologies.
    Yang F; Liao X; Tian Y; Li G
    Biotechnol J; 2017 Apr; 12(4):. PubMed ID: 28166394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfluidic detection of human diseases: From liquid biopsy to COVID-19 diagnosis.
    Jiang K; Jokhun DS; Lim CT
    J Biomech; 2021 Mar; 117():110235. PubMed ID: 33486262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.